Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment

ClinicalTrials.gov ID: NCT01170962

Public ClinicalTrials.gov record NCT01170962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2B Study of BMS-790052 in Combination With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Infected Subjects Who Are Null or Partial Responders to Prior Treatment With Peginterferon Alfa Plus Ribavirin Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether BMS-790052 added to Peginterferon Alfa-2a and ribavirin can result in higher cure rates in patients who previously failed therapy and may have limited response to retreatment with Peginterferon Alfa-2a and ribavirin alone.

Study identification

NCT ID
NCT01170962
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
512 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2010
Primary completion
May 31, 2012
Completion
Nov 30, 2012
Last update posted
Oct 11, 2015

2010 – 2012

United States locations

U.S. sites
35
U.S. states
19
U.S. cities
31
Facility City State ZIP Site status
Alabama Liver & Digestive Specialists (Alds) Montgomery Alabama 36116
Scripps Clinic La Jolla California 92037
CLI Los Angeles California 90048
Desta Digestive Disease Medical Center San Diego California 92114
University Of California At San Francisco San Francisco California 94110
California Pacific Medical Center San Francisco California 94115
Kaiser Permanente Medical Center San Francisco California 94118
Transplant Center And Hepatology Clinic, B-154 Aurora Colorado 80045
Yale University School Of Medicine New Haven Connecticut 06520
University Of Florida Hepatology Gainesville Florida 32610-0277
Miami Research Associates South Miami Florida 33143
Indiana University Indianapolis Indiana 46202
Ochsner Clinic Foundation New Orleans Louisiana 70121
Mercy Medical Center Baltimore Maryland 21202
Digestive Disease Associates, P.A. Baltimore Maryland 21229
Johns Hopkins Medical Institutions Lutherville Maryland 21093
The Research Institute Springfield Massachusetts 01105
Saint Louis University St Louis Missouri 63104
Samuel S. Stratton Vamc Albany New York 12208
James Sungsik Park, M.D. C.N.S.C. Great Neck New York 11201
Upper Delaware Valley Infectious Diseases, Pc Monticello New York 12701
University Of Rochester Medical Center Rochester New York 14642
James J Peters Vamc The Bronx New York 10468
University Of North Carolina, Chapel Hill Chapel Hill North Carolina 27599-7584
Carolinas Center For Liver Disease Statesville North Carolina 28677
Healthcare Research Consultants Tulsa Oklahoma 74135
University Of Pennsylvania Philadelphia Pennsylvania 19104
University Gastroenterology Providence Rhode Island 02905
Nashville Medical Research Institute Nashville Tennessee 37205
North Texas Research Institute Arlington Texas 76012
Liver Associates Of Texas Houston Texas 77030
St. Luke'S Episcopal Hospital - Baylor College Of Medicine Houston Texas 77030
Alamo Medical Research San Antonio Texas 78215
Metropolitan Research Fairfax Virginia 22031
Dean Clinic Madison Wisconsin 53715

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01170962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2015 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01170962 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →